CARNOSINE RESEARCH

Study: “Brain type carnosinase in dementia: a pilot study” (2007).

Summary: Reduced brain carnosinase activity was observed in dementia patients, suggesting a role for carnosine metabolism in cognitive disorders.

Study: “Carnosine supplementation in elderly subjects: A randomized, double-blind, placebo-controlled trial” (2016).

Summary: Carnosine supplementation improved cognitive function and physical performance in elderly subjects, indicating broad health benefits.

Study: “L-homocarnosine, L-carnosine, and anserine attenuate brain oxidative damage in a pentylenetetrazole-induced epilepsy model of ovariectomized rats” (2018).

Summary: Carnosine, L-homocarnosine, and anserine reduced oxidative brain damage in ovariectomized rats with induced epilepsy, suggesting neuroprotective effects.

Study: “Carnosine is neuroprotective against permanent focal cerebral ischemia in mice” (2007).

Summary: Carnosine protected mice against permanent focal cerebral ischemia, indicating potential as a neuroprotective agent in stroke models.

Study: “β-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer’s disease” (2013).

Summary: Carnosine supplementation improved cognitive function in Alzheimer’s model mice fed a high-fat diet, suggesting a role in mitigating neurodegenerative decline.

Study: “Carnosine and its possible roles in nutrition and health” (2009).

Summary: Carnosine showed neuroprotective effects in animal models of brain injury, supporting its potential in neurological health.

Study: “Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders” (2022).

Summary: Carnosine modulates brain cell activity through multiple mechanisms, showing therapeutic potential for neurodegenerative disorders like Alzheimer’s and Parkinson’s.

Study: “Carnosine in health and disease” (2018).

Summary: Carnosine exhibits neuroprotective effects in brain tissues, with potential applications in treating neurological disorders due to its antioxidant and anti-inflammatory properties.

Study: “Carnosine and the processes of ageing” (2016).

Summary: Carnosine’s antioxidant properties may protect against age-related neurological decline, supporting its use in brain health.

Study: “Carnosine prevents necrotic and apoptotic death of rat thymocytes via mitochondrial pathway” (2009).

Summary: Carnosine prevented cell death in rat thymocytes in vitro, suggesting anti-aging effects by protecting against mitochondrial dysfunction.

Study: “Unveiling the Hidden Therapeutic Potential of Carnosine, a Molecule with a Multimodal Mechanism of Action: A Position Paper” (2022).

Summary: Carnosine’s anti-aging effects stem from its ability to detoxify reactive oxygen species and prevent protein cross-linking, supporting its use in age-related conditions.

Study: “Physiology and pathophysiology of carnosine” (2013).

Summary: Carnosine’s antioxidant and anti-glycation properties make it a promising agent for combating age-related cellular damage and senescence.

Study: “Carnosine and the processes of ageing” (2016).

Summary: Carnosine’s anti-glycation and antioxidant effects may slow aging processes, particularly in cellular senescence (duplicate from Brain Health, included for partial fit).

Study: “A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus” (2010).

Summary: A carnosinase gene polymorphism was associated with increased mortality and progression to end-stage renal disease in type 1 diabetes patients, indicating a genetic link to carnosine metabolism.

Study: “Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial” (2016).

Summary: Carnosine supplementation improved insulin sensitivity in humans, suggesting potential benefits for glucose metabolism in diabetes management.

Study: “Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice” (2014).

Summary: Carnosine supplementation reduced plasma triglycerides and altered plaque composition in diabetic mice, suggesting cardiovascular benefits in diabetes.

Study: “Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats” (2008).

Summary: Carnosine eye drops prevented cataract formation in diabetic rats, highlighting its protective effects against diabetic complications.

Study: “Carnosine supplementation protects rat brain tissue against ethanol-induced oxidative stress” (2010).

Summary: Carnosine reduced oxidative stress in diabetic rat brains exposed to ethanol, suggesting protective effects against diabetic neurological complications.

Study: “Effects of supplementation with carnosine and other histidine-containing dipeptides on chronic disease risk factors and outcomes: protocol for…” (2018).

Summary: The protocol outlines research to evaluate carnosine’s potential in reducing chronic disease risk factors, particularly in diabetes and related complications.

Study: “Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation” (2021).

Summary: Carnosine shows promise as a functional food ingredient for managing diabetic nephropathy and other chronic conditions due to its antioxidant properties.

Study: “Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance” (2010).

Summary: Beta-alanine supplementation increased muscle carnosine levels, enhancing exercise performance in humans.

Study: “Beta-alanine supplementation augments muscle carnosine content and attenuates fatigue during repeated isokinetic contraction bouts in trained sprinters” (2007).

Summary: Beta-alanine supplementation increased muscle carnosine and reduced fatigue in sprinters, improving performance during intense exercise.

Study: “Effect of beta-alanine and carnosine supplementation on muscle contractility in mice” (2013).

Summary: Carnosine and beta-alanine supplementation improved muscle contractility in mice, supporting their role in enhancing muscle function.

Study: “Carnosine: from exercise performance to health” (2013).

Summary: Carnosine enhances exercise performance by buffering muscle pH and has broader health benefits due to its antioxidant effects.

Study: “A Systematic Risk Assessment and Meta-Analysis on the Use of Oral β-Alanine Supplementation” (2019).

Summary: Beta-alanine supplementation, which increases carnosine levels, is safe and effective for improving exercise performance, with minimal side effects.

Study: “Role Niehs-Bolton effect of carnosine and anserine on exercise performance and quality of life in older adults: A systematic review and meta-analysis” (2020).

Summary: Carnosine supplementation improved physical performance and quality of life in older adults, supporting its ergogenic benefits.

Study: “Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats” (2008).

Summary: Carnosine eye drops reduced cataract formation in diabetic rats, suggesting a protective role against ocular diabetic complications.

Study: “Physiology and pathophysiology of carnosine” (2013).

Summary: Carnosine’s antioxidant properties may offer therapeutic potential for ocular diseases, including cataracts.

Study: “Unveiling the Hidden Therapeutic Potential of Carnosine, a Molecule with a Multimodal Mechanism of Action: A Position Paper” (2022).

Summary: Carnosine’s antioxidant effects may support skin health by protecting against UV damage and aiding wound healing.

Study: “Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling” (2019).

Summary: Carnosine inhibited glioblastoma cell growth in vitro, independent of the PI3K/Akt/mTOR pathway, suggesting a novel anti-cancer mechanism.

Study: “Carnosine retards reactive oxygen species-mediated hamster cheek pouch carcinogenesis” (2010).

Summary: Carnosine reduced reactive oxygen species-mediated carcinogenesis in hamster cheek pouch cells in vitro, indicating anti-cancer potential.

Study: “Carnosine inhibits migration and invasion of colorectal cancer cells by disrupting the STAT3 signaling pathway” (2021).

Summary: Carnosine inhibited migration and invasion of colorectal cancer cells in vitro by disrupting STAT3 signaling, suggesting anti-metastatic effects.

Study: “Unveiling the Hidden Therapeutic Potential of Carnosine, a Molecule with a Multimodal Mechanism of Action: A Position Paper” (2022).

Summary: Carnosine inhibits cancer cell proliferation and may enhance chemotherapy efficacy, offering potential as an anti-cancer agent.

Study: “Carnosine in health and disease” (2018).

Summary: Carnosine’s anti-proliferative effects on cancer cells suggest therapeutic potential in oncology, particularly for glioblastoma.

Study: “The hepatoprotective effect of carnosine against ischemia/reperfusion liver injury in rats” (2007).

Summary: Carnosine protected rat livers from ischemia/reperfusion injury, indicating hepatoprotective effects.

Study: “Distribution of carnosine-like peptides in the nervous system of developing and adult zebrafish (Danio rerio) and embryonic effects of chronic carnosine exposure” (2009).

Summary: Carnosine-like peptides were distributed in the zebrafish nervous system, with chronic exposure affecting embryonic development.

Study: “Carnosine protects against cisplatin-induced acute kidney injury in mice” (2015).

Summary: Carnosine reduced cisplatin-induced kidney damage in mice, suggesting renoprotective effects.

Study: “Carnosine: its properties, functions and potential therapeutic applications” (1992).

Summary: Carnosine’s antioxidant and chelating properties suggest broad therapeutic applications across various health conditions.

Study: “Carnosine, Small but Mighty—Prospect of Use as Functional Ingredient for Functional Food Formulation” (2021).

Summary: Carnosine’s multifaceted benefits, including cardiovascular protection, support its use as a functional food ingredient.

Study: “Carnosine and its possible roles in nutrition and health” (2009).

Summary: Carnosine’s antioxidant properties support its potential in cardiovascular and immune health.

Study: “Carnosine: physiological properties and therapeutic potential” (2000).

Summary: Carnosine’s physiological roles, including pH buffering and metal chelation, suggest diverse therapeutic applications beyond specific diseases.

Study: “Carnosine and anserine as modulators of neutrophil function” (2018).

Summary: Carnosine and anserine modulated neutrophil function, indicating potential in immune system regulation.

Study: “Carnosine metabolism in health and disease” (2023).

Summary: Carnosine metabolism influences various physiological processes, with potential therapeutic roles in multiple health contexts.

Study: “Carnosine-induced neuroprotection involves mitochondrial preservation and H2O2 detoxification” (2006).

Summary: Carnosine protected neuronal cells in vitro by preserving mitochondrial function and detoxifying hydrogen peroxide, suggesting broad cellular protective effects.

Study: “Carnosine and homocarnosine interaction with membrane phospholipids” (2009).

Summary: Carnosine and homocarnosine interacted with membrane phospholipids in vitro, indicating a role in stabilizing cellular membranes.

Study: “Carnosine as an inhibitor of protein carbonylation in vitro” (2008).

Summary: Carnosine inhibited protein carbonylation in vitro, suggesting a role in protecting proteins from oxidative damage.